Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3237501 | Emergency Medicine Clinics of North America | 2007 | 10 Pages |
Abstract
There are several classes of oral diabetes medications available in the United States, including sulfonylureas, meglitinides, biguanides, glitazones, and α-glucosidase inhibitors. These different classes have various mechanisms of action, giving each class a unique potential for toxicity that necessitates a distinct approach to evaluation, treatment, and disposition of each class of drug. The practicing emergency physician must have an understanding of these differences to safely care for patients exposed to these medications.
Related Topics
Health Sciences
Medicine and Dentistry
Emergency Medicine
Authors
Adam K. Rowden, Charles J. Fasano,